| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50007 |
Ca Ski |
human |
uterine cervix |
Human epidermoid cervical cancer cell line. |
|
| 2 | general cells |
IFO50009 |
G-361 |
human |
melanoma |
This cell line produces melanin. |
|
| 3 | general cells |
IFO50016 |
Chang Liver |
human |
liver |
Hela markers* |
|
| 4 | general cells |
IFO50036 |
P388D1 |
mouse |
lymph node |
lymphoid neoplasm, derived from P388, (DBA/2 mouse) |
|
| 5 | general cells |
IFO50046 |
Raji |
human |
maxilla |
lymphoma, Burkitt's |
|
| 6 | general cells |
IFO50074 |
HFL1 |
human |
lung |
Normal diploid fibroblasts with limited life span. |
|
| 7 | general cells |
IFO50267 |
PB-3c |
mouse |
bone marrow |
IL-3-dependent mouse bone marrow cell line. |
|
| 8 | general cells |
IFO50268 |
EHS |
mouse |
spontaneous tumor |
This cell line secretes basement membrane matrix including laminin and type IV collagen. Non cultivable in vitro. |
|
| 9 | general cells |
IFO50288 |
U-251 MG |
human |
brain |
astrocytoma, GFAP-positive |
|
| 10 | general cells |
IFO50312 |
SNG-II |
human |
uterine endometrium |
endometrial adenocarcinoma |
|
| 11 | general cells |
IFO50323 |
BOKU |
human |
uterine cervix |
cervical squamous cell carcinoma |
|
| 12 | general cells |
IFO50350 |
Hs68 |
human |
foreskin |
Normal diploid fibroblasts with limited life span. |
|
| 13 | general cells |
IFO50356 |
KNS-42 |
human |
brain |
glioma, GFAP-positive, S-100 and NSE-negative |
|
| 14 | general cells |
IFO50359 |
KNS-81 |
human |
brain |
glioma, GFAP and S-100-positive, NSE-negative |
|
| 15 | general cells |
IFO50362 |
MOLT-4 |
human |
peripheral blood |
leukemia, acute T lymphoblastic |
|
| 16 | general cells |
IFO50380 |
TLR3 |
mouse |
liver |
P450IA1 mRNA is induced by methylcholanthrene. Growth temperature is 33 C. |
|
| 17 | general cells |
IFO50415 |
C3H/10T1/2-clone8 |
mouse |
embryo |
This cell line is useful for transformation studies. |
|
| 18 | general cells |
JCRB0017 |
P388 |
mouse |
|
MCA induced lymphoid mouse neoplasma cell line. |
|
| 19 | general cells |
JCRB0236 |
KG-1-C |
human |
brain |
mixed glioma, GFAP-negative, S-100-positive (growth is very slow). |
|
| 20 | general cells |
JCRB0411 |
AH66tc |
rat |
liver |
ascites hepatoma, (Donryu rat) |
|
| 21 | general cells |
JCRB0429 |
KMS-12-BM |
human |
bone marrow |
myeloma, late stage of B-cell differentiation |
|
| 22 | general cells |
JCRB0612 |
GOTO |
human |
adrenal gland |
neuroblastoma, adrenal gland |
|
| 23 | general cells |
JCRB0728 |
A9(7151)-3 |
human chromosome-introduced |
hybrid |
contains human chromosome 17pter>17q11::Xq11>Xqter (MTA with Tottori Univ. is required.) |
|
| 24 | general cells |
JCRB0729 |
A9(3884)-1 |
human chromosome-introduced |
hybrid |
contains human chromosome 16pter>16q24::Xq26>Xqter (MTA with Tottori Univ. is required.) |
|
| 25 | general cells |
JCRB0831 |
HO-1-N-1 |
human |
buccal mucosa |
squamous carcinoma, buccal mucosa |
|
| 26 | general cells |
JCRB1006.7 |
OUMS-36T-7 |
human |
embryo |
hTRT gene transfected normal human embryo fibroblast cell line. |
|
| 27 | general cells |
JCRB1009 |
RERF-GC-1B |
human |
stomach |
Human gastric cancer cell line established from a metastatic tissue of pyloric lymph nodes. |
|
| 28 | general cells |
JCRB1045 |
OVMANA |
human |
ovary |
Human cell line derived from ovarian tumour. |
|
| 29 | general cells |
JCRB1081 |
MS-1-L |
human |
pleural effusion |
Human lung small cell carcinoma from pleural effusion. |
|
| 30 | general cells |
JCRB1129 |
KUSA-H1 |
mouse |
Bone marrow |
mouse osteoblastic cell line |
|
| 31 | general cells |
JCRB1191 |
KMS-28PE |
human |
pleural effusion |
Human myeloma cell line. |
|
| 32 | general cells |
JCRB1200 |
NCC-RbC-53 |
human |
primary retinoblastoma |
Human retinoblastoma cell line. The growth is extremely slow. |
|
| 33 | general cells |
JCRB1222.10 |
HGH1.41.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
| 34 | general cells |
JCRB1349 |
Ex-3LL |
mouse |
|
Variant cell line possessing enhanced lung metastasis ability derived from Lewis lung cancer (3LL). |
|
| 35 | general cells |
JCRB1358.02 |
SRBC-P18-3-8 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 36 | general cells |
JCRB1358.08 |
SRBC-F31-19-1 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 37 | general cells |
JCRB1362 |
HCT-2 |
hamster, Syrian |
spleen |
Hamster spleen lymphocytes transformed by human T-cell leukemia virus type I. |
|
| 38 | general cells |
JCRB1419 |
KYSE410 |
human |
esophagus |
Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 39 | general cells |
JCRB1425 |
KYSE3410 |
human |
esophagus |
Human squamous cell carcinoma cell line established from esophageal cancer. |
|
| 40 | general cells |
JCRB1475 |
Nalm-6-MSH+ |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POL(WT), TK+/-) |
|
| 41 | general cells |
JCRB1657 |
HuCCA-1 |
human |
intrahepatic bile duct |
Human cell line derived from cholangiocarcinoma. |
|
| 42 | general cells |
JCRB1894 |
TCC-MESO-1 |
human |
left pleura |
Cell line of malignant pleural mesothelioma. TCC-MESO-2 established from same individual.
|
|
| 43 | general cells |
JCRB1916 |
TCC-NECT-2 |
human |
duodenum |
Duodenal neuroendocrine tumor. Derived from metastatic site: Ascites. |
|
| 44 | general cells |
JCRB1921 |
TCC-Pan2 |
human |
ascites |
Pancreatic ductal adenocarcinoma. Cell line established from ascites. |
|
| 45 | general cells |
JCRB1928 |
Sui76 |
human |
liver metastasis |
Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from liver metastasis. |
|
| 46 | general cells |
JCRB2207 |
A9(Neo7) |
human chromosome-introduced |
skin |
contains human chromosome # 7 (MTA with Tottori Univ. is required.) |
|
| 47 | general cells |
JCRB2214 |
A9(Hygro14) |
human chromosome-introduced |
skin |
contains human chromosome #14 (MTA with Tottori Univ. is required.) |
|
| 48 | general cells |
JCRB9014 |
3T3 L1 |
mouse |
embryo |
Clonal subline of the mouse 3T3 that accumulate large amounts of triglyceride fat when the cells are in the resting state. |
|
| 49 | general cells |
JCRB9031 |
MOLT-4 |
human |
peripheral blood |
leukemia, acute T lymphoblastic |
|
| 50 | general cells |
JCRB9074 |
G-361 |
human |
skin |
malignant melanoma, skin |
|
| 51 | general cells |
JCRB9081 |
L6 |
rat |
muscle |
skeletal muscle myoblast |
|
| 52 | general cells |
JCRB9089 |
CCRF S-180 II |
mouse |
sarcoma |
S-180 sarcoma derivative |
|
| 53 | general cells |
JCRB9091 |
Y3-Ag 1.2.3 |
rat |
myeloma |
myeloma, kappa secreting, 8-azaguanine resistant, (Lou rat) |
|
| 54 | general cells |
JCRB9125 |
PG-4(S+L-) |
cat |
brain |
brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.